A new study by Richard Horowitz, MD and Phyllis Freeman, MD has been published in Antibiotics that evaluates the efficacy of using short-term high dose pulsed dapsone combination therapy (HDDCT) […]
Search Results for: dapsone
Richard Horwitz, MD, et al., have published a new case study and retrospective chart review of 40 patients on double dose dapsone combination therapy (DDD CT) in the journal Antibiotics.
The study found that of the 40 patients analyzed, an 8-week course of dapsone combined with doxycycline and rifampin effectively improved symptoms in 98% of patients, as well as led to long-term remission in 45% of the total patients studied, even though most of the individuals were ill for a decade or longer.
Promising Dapsone Research/WG Meeting: Access to Care Under Attack/CDC Announces Nat’l Framework/Researchers ID Bat Tick in NJ/NIH Grants $1.9M for Lyme Vaccine/Lyme & Pregnancy Study/Oct 27 Next TBDWG Mtg
Dr. Richard Horowitz et al. just published a new in vitro study on dapsone (diaminodiphenyl sulfone) and dapsone combination therapy (DDS CT). The study is suggestive that dapsone combination therapy may well characterize both a novel and successful option to treat Borrelia burgdorferi “persister” cells, which are the biofilm form of the bacteria.
Lyme Treatment/Neuro & Psych Symptoms/Severe COVID/Kundalini Yoga/B. Miyamotoi/Lyme Vax Trials/FDA Warning/New Lyme Test/Longhorned Tick/NJ: Send Ticks/TBDWG/COVID Brain/Nebraska/Rickettsia/Kill Ticks
A new study by Richard Horowitz, MD and Phyllis Freeman, MD has been published in Antibiotics that evaluates the efficacy of using short-term, high dose, and pulsed dapsone combination therapy (HDDCT) in the treatment of Chronic Lyme disease/Post Treatment Lyme Disease Syndrome (PTLDS).
Dr. Richard Horowitz Medical director, Hudson Valley Healing Arts Center
Board certified internal medicine. Member NYS DOH Tick-borne Disease Working Group 2021-2022. Member HHS Tick-borne Disease Working Group 2017-2019. Co-chair HHS Other Tick-borne Diseases and Co-infections subcommittee 2017-2019. Member, HHS Babesia and Other Tick-borne Pathogens 2019-2020
BACKGROUND: The 17th Working Group Meeting turned out to be a referendum on the Patient Chapter of the upcoming 2020 Working Group report. The previous 9 months of the WG […]
May Awareness LDA Guest Blogger, Dr. Richard I. Horowitz, MD, PLLC: “Why Patients with Chronic Lyme-MSIDS Should Have Hope” …. These doctors all wanted to know how to treat their sickest and most resistant patients with chronic Lyme symptoms who were also being adversely affected by environmental illness […]